Open Payments

ANDREW C KIM

Type
Physician · Allopathic & Osteopathic Physicians / Orthopaedic Surgery
Where
ARCATA, CA
NPI
1609978618
Received
$1,745 in 14 records, 2019 to 2025
As principal investigator
$404,297 of research payments to others in 42 records
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment2$134
2024General payment2$77
2023General payment2$87
2021General payment3$1,345
2020General payment2$38
2019General payment3$63

By company

CompanyRecordsAmountYears
ImpactOrtho, Inc.1$1,2002021
Medical Device Business Services, Inc.4$1642023–2024
Zimmer Biomet Holdings, Inc.2$1342025
AstraZeneca Pharmaceuticals LP1$1262021
PFIZER INC.5$1022019–2020
Medtronic, Inc.1$182021

By nature of payment

NatureRecordsAmount
Education3$1,334
Food and Beverage11$411

Records

DateCompanyAmountNatureFormProductStudyYear
2025-06-21Zimmer Biomet Holdings, Inc.$67EducationIn-kind items and servicesOXFORD PARTIAL KNEE Device, Knees2025
2025-06-20Zimmer Biomet Holdings, Inc.$67EducationIn-kind items and servicesOxford Device, Knees2025
2024-02-14Medical Device Business Services, Inc.$40Food and BeverageIn-kind items and servicesINHANCE Device, Ortho-Shoulder2024
2024-02-14Medical Device Business Services, Inc.$36Food and BeverageIn-kind items and servicesINHANCE Device, Ortho-Shoulder2024
2023-03-09Medical Device Business Services, Inc.$29Food and BeverageIn-kind items and servicesINHANCE Device, Ortho-Shoulder2023
2023-03-08Medical Device Business Services, Inc.$57Food and BeverageIn-kind items and servicesACTIS Device, Ortho-Hip2023
2021-11-11AstraZeneca Pharmaceuticals LP$126Food and BeverageIn-kind items and servicesBREZTRI Drug, Respiratory2021
2021-03-31Medtronic, Inc.$18Food and BeverageIn-kind items and servicesReveal LINQ Device, Cardiac Diagnostics and Monitoring2021
2021-03-10ImpactOrtho, Inc.$1,200EducationIn-kind items and services2021
2020-02-25PFIZER INC.$25Food and BeverageIn-kind items and servicesCHANTIX Drug, NEUROSCIENCE;TOBACCO DEPENDENCE2020
2020-02-04PFIZER INC.$12Food and BeverageIn-kind items and servicesFLECTOR Drug, INFLAMMATION;PAIN2020
2019-08-07PFIZER INC.$18Food and BeverageIn-kind items and servicesEMBEDA Drug, NEUROSCIENCE;PAIN2019
2019-03-19PFIZER INC.$22Food and BeverageIn-kind items and servicesCHANTIX Drug, NEUROSCIENCE;TOBACCO DEPENDENCE2019
2019-02-07PFIZER INC.$22Food and BeverageIn-kind items and servicesELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE2019

Research payments naming this person as principal investigator

DateCompanyPaid toAmountStudyYear
2025-12-12Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$3,870A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2025-11-19Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$5,160A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2025-11-07Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$4,362A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2025-11-03Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$1,325A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2025-10-10Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$2,325A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2025-09-19Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$9,498A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2025-08-25Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$7,030A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2025-08-13Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$4,598A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2025-07-23Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$1,626A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2025-06-23Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$1,626A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2025-06-20Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$9,924A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2025-05-21Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$5,208A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2025-04-23Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$1,368A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2025-03-21Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$8,847A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2025-02-19Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$6,736A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2025-01-22Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$10,207A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and 2025
2024-12-16Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$9,31970033093AFL30022024
2024-11-20Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$6,80570033093AFL30022024
2024-11-13Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$4,34070033093AFL30022024
2024-10-23Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$2,73670033093AFL30022024
2024-09-18Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$8,13070033093AFL30022024
2024-08-19Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$8,31970033093AFL30022024
2024-07-26Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$5,16970033093AFL30022024
2024-06-25Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$6,36970033093AFL30022024
2024-06-14Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$12,11970033093AFL30022024
2024-06-07Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$6,30270033093AFL30022024
2024-05-22Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$7,30370033093AFL30022024
2024-04-26Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$2,58270033093AFL30022024
2024-03-25Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$8,53470033093AFL30022024
2024-03-04Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$29,96470033093AFL30022024
2024-01-26Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$35,98870033093AFL30022024
2023-12-20Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$5,48370033093AFL30022023
2023-12-15Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$15,50470033093AFL30022023
2023-11-17Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$10,69070033093AFL30022023
2023-10-25Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$13,21170033093AFL30022023
2023-09-22Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$3,83470033093AFL30022023
2023-09-15Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$30,09470033093AFL30022023
2023-08-16Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$45,87670033093AFL30022023
2023-07-26Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$4,94970033093AFL30022023
2023-07-10Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$22570033093AFL30022023
2023-06-27Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$12,20370033093AFL30022023
2023-06-16Janssen Research & Development, LLCAllegiance Rsrch Specialists, Llc$24,53970033093AFL30022023

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Humboldt CountyArcata city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Arcata, CA, county Humboldt County, CA, state California; placed by its city name.

MeasurePlace (city or town)
Arcata, CA
County
Humboldt County, CA
State
California
Population B0100318,607134,54139,287,377
Population, 2020 census P118,857136,46339,538,223
Median age B0100228.139.937.9
Under 18 B0100111.8%18.8%22.0%
65 and over B0100114.2%19.8%15.7%
Households B110017,88454,92213,548,091
Foreign born B050024.6%6.2%27.0%
Median household income B19013$46,713$61,160$99,122
Median family income B19113$91,661$83,067$113,346
Per capita income B19301$32,307$36,080$49,513
Poverty rate B1700127.2%18.7%12.0%
Unemployment rate B2302511.9%9.0%6.6%
Civilian labor force B2302510,54163,65920,068,466
Mean commute (minutes) B0801317.819.028.7
Bachelor's degree or higher B1500346.3%33.1%37.1%
Housing units B250018,63662,88314,644,735
Owner-occupied B2500336.4%56.5%55.9%
Renters B2500363.6%43.5%44.1%
Median home value B25077$484,600$446,900$734,700
Median gross rent B25064$1,327$1,287$2,036
White, not Hispanic B0300270.6%69.5%33.8%
Black B030023.0%1.3%5.2%
Hispanic or Latino B0300216.0%14.2%40.2%
Asian B030021.1%3.0%15.3%
American Indian and Alaska Native B030020.8%3.1%0.3%

Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); Unemployment rate: 5.5% in Sep 2016 to 5.1% in Sep 2026; low 3.8%, high 16.1% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Arcata, CA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.